rs145564837

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 1P and 8B. BA1PP3

This summary comes from the ClinGen Evidence Repository: The filtering allele frequency of the p.Ala342Val variant in the MYO6 gene is 0.21% for European (non-Finnish) chromosomes by gnomAD (304/129090 with 95% CI), and one homozygous European (Finnish) individual, which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen Hearing Loss Expert Panel for autosomal dominant hearing loss variants (BA1). The REVEL computational prediction analysis tool produced a score of 0.905, however, this information is not predictive of pathogenicity on its own and is not considered in conflict with evidence that supports a benign interpretation. In summary, the HL EP classified this variant as benign. ACMG/AMP criteria applied, as specified by the Hearing Loss Expert Panel: BA1. LINK:https://erepo.genome.network/evrepo/ui/classification/CA135587/MONDO:0019497/005

Frequency

Genomes: 𝑓 0.0012 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 2 hom. )

Consequence

MYO6
NM_004999.4 missense

Scores

13
5
1

Clinical Significance

Benign reviewed by expert panel U:2B:11

Conservation

PhyloP100: 7.54

Publications

8 publications found
Variant links:
Genes affected
MYO6 (HGNC:7605): (myosin VI) This gene encodes a reverse-direction motor protein that moves toward the minus end of actin filaments and plays a role in intracellular vesicle and organelle transport. The protein consists of a motor domain containing an ATP- and an actin-binding site and a globular tail which interacts with other proteins. This protein maintains the structural integrity of inner ear hair cells and mutations in this gene cause non-syndromic autosomal dominant and recessive hearing loss. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2014]
MYO6 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 22
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • nonsyndromic genetic hearing loss
    Inheritance: AR, AD Classification: DEFINITIVE, MODERATE Submitted by: G2P, ClinGen
  • autosomal recessive nonsyndromic hearing loss 37
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_004999.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

PP3
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004999.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYO6
NM_004999.4
MANE Select
c.1025C>Tp.Ala342Val
missense
Exon 11 of 35NP_004990.3
MYO6
NM_001368865.1
c.1025C>Tp.Ala342Val
missense
Exon 11 of 36NP_001355794.1A0A590UJ40
MYO6
NM_001368866.1
c.1025C>Tp.Ala342Val
missense
Exon 11 of 35NP_001355795.1A0A1Y0BRN3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYO6
ENST00000369977.8
TSL:1 MANE Select
c.1025C>Tp.Ala342Val
missense
Exon 11 of 35ENSP00000358994.3Q9UM54-1
MYO6
ENST00000615563.4
TSL:1
c.1025C>Tp.Ala342Val
missense
Exon 10 of 32ENSP00000478013.1Q9UM54-2
MYO6
ENST00000664640.1
c.1025C>Tp.Ala342Val
missense
Exon 11 of 36ENSP00000499278.1A0A590UJ40

Frequencies

GnomAD3 genomes
AF:
0.00122
AC:
185
AN:
152124
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000290
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000755
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00226
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00133
AC:
334
AN:
251308
AF XY:
0.00137
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.000397
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00166
Gnomad NFE exome
AF:
0.00239
Gnomad OTH exome
AF:
0.00196
GnomAD4 exome
AF:
0.00153
AC:
2231
AN:
1461642
Hom.:
2
Cov.:
31
AF XY:
0.00146
AC XY:
1065
AN XY:
727122
show subpopulations
African (AFR)
AF:
0.000269
AC:
9
AN:
33462
American (AMR)
AF:
0.000201
AC:
9
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.000459
AC:
12
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39682
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86250
European-Finnish (FIN)
AF:
0.00245
AC:
131
AN:
53418
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.00179
AC:
1990
AN:
1111844
Other (OTH)
AF:
0.00131
AC:
79
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
119
237
356
474
593
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00122
AC:
185
AN:
152242
Hom.:
0
Cov.:
32
AF XY:
0.00118
AC XY:
88
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.000289
AC:
12
AN:
41566
American (AMR)
AF:
0.000393
AC:
6
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.000755
AC:
8
AN:
10596
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00226
AC:
154
AN:
68010
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
10
20
30
40
50
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00170
Hom.:
0
Bravo
AF:
0.00111
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00169
EpiControl
AF:
0.00119

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
7
not provided (8)
-
-
1
Autosomal dominant nonsyndromic hearing loss 22 (1)
-
1
-
Autosomal recessive nonsyndromic hearing loss 37 (1)
-
-
1
MYO6-related disorder (1)
-
-
1
Nonsyndromic genetic hearing loss (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.93
BayesDel_addAF
Uncertain
0.14
D
BayesDel_noAF
Pathogenic
0.44
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.87
D
Eigen
Pathogenic
0.82
Eigen_PC
Pathogenic
0.78
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.96
D
M_CAP
Pathogenic
0.33
D
MetaRNN
Benign
0.25
T
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
3.5
H
PhyloP100
7.5
PrimateAI
Pathogenic
0.84
D
PROVEAN
Uncertain
-3.8
D
REVEL
Pathogenic
0.91
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.0020
D
gMVP
0.88
Mutation Taster
=16/84
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs145564837;
hg19: chr6-76558195;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.